Search research articles
Contact Us
Filters
Showing results (121-130 of 471) with videos related to
Page
of 48
Sort By:
Kardiologia Polska
|
December 20, 2005
[Diagnosis and treatment of chronic heart disease. Guidelines of the European Society of Cardiology. Revision 2005]
Karl Swedberg, John Cleland, Henry Dargie, et al.
The American Journal of Cardiology
|
September 9, 2008
Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction
Jasmine Grewal, Robert S McKelvie, Hans Persson, et al.
Patient Education and Counseling
|
September 6, 2005
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial
Inger Ekman, Gull Andersson, Kurt Boman, et al.
European Heart Journal
|
August 31, 2011
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study
Inger Ekman, Olivier Chassany, Michel Komajda, et al.
Circulation
|
April 17, 2002
Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure
Karl Swedberg, Michael R Bristow, Jay N Cohn, et al.
BMC Health Services Research
|
September 1, 2005
Heart failure guidelines and prescribing in primary care across Europe
Heidrun B Sturm, Wiek H van Gilst, Karl Swedberg, et al.
European Journal of Heart Failure
|
May 23, 2013
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure
Jan-Christian Reil, Michele Robertson, Ian Ford, et al.
European Journal of Heart Failure
|
October 14, 2017
Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT
Michael Böhm, Michel Komajda, Jeffrey S Borer, et al.
European Journal of Heart Failure
|
June 20, 2017
Heart rate and its reduction in chronic heart failure and beyond
Aleksandra Nikolovska Vukadinović, Davor Vukadinović, Jeffrey Borer, et al.
Heart Failure Reviews
|
May 10, 2007
Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy
Leonardo De Luca, Gregg C Fonarow, Kirkwood F Adams, et al.
Page
of 48
Search research articles
Search
Showing results (121-130 of 471) with videos related to
Sort By:
Page
of 48
Kardiologia Polska
|
December 20, 2005
[Diagnosis and treatment of chronic heart disease. Guidelines of the European Society of Cardiology. Revision 2005]
Karl Swedberg, John Cleland, Henry Dargie, et al.
The American Journal of Cardiology
|
September 9, 2008
Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction
Jasmine Grewal, Robert S McKelvie, Hans Persson, et al.
Patient Education and Counseling
|
September 6, 2005
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial
Inger Ekman, Gull Andersson, Kurt Boman, et al.
European Heart Journal
|
August 31, 2011
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study
Inger Ekman, Olivier Chassany, Michel Komajda, et al.
Circulation
|
April 17, 2002
Effects of sustained-release moxonidine, an imidazoline agonist, on plasma norepinephrine in patients with chronic heart failure
Karl Swedberg, Michael R Bristow, Jay N Cohn, et al.
BMC Health Services Research
|
September 1, 2005
Heart failure guidelines and prescribing in primary care across Europe
Heidrun B Sturm, Wiek H van Gilst, Karl Swedberg, et al.
European Journal of Heart Failure
|
May 23, 2013
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure
Jan-Christian Reil, Michele Robertson, Ian Ford, et al.
European Journal of Heart Failure
|
October 14, 2017
Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT
Michael Böhm, Michel Komajda, Jeffrey S Borer, et al.
European Journal of Heart Failure
|
June 20, 2017
Heart rate and its reduction in chronic heart failure and beyond
Aleksandra Nikolovska Vukadinović, Davor Vukadinović, Jeffrey Borer, et al.
Heart Failure Reviews
|
May 10, 2007
Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy
Leonardo De Luca, Gregg C Fonarow, Kirkwood F Adams, et al.
Page
of 48